Home > Drug Search >
  • company_query: Beijing Ruiyunhai Biotechnology
  •   > 
Drug Filter
Category:
chemistry (22) biology (4)
Status:
Approved (3) Phase Ⅲ (1) Phase Ⅱ (7) Phase Ⅰ (13) IND Filing (2)
Clinical Stage:
Pending (1) Active (19) Discontinued (2)
Bio-Type:
CAR T cell therapy (1) TCR therapy (1) Vaccine (2)
Indication:
Acute myeloid Leukemia (AML) (2) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Gastric cancer (1) Glioblastoma multiforme (1) HBV infection (1) HCV infection (1) Hepatocellular carcinoma (HCC) (1) Lung cancer (2) Lymphoma (4) Malignancies (1) Multiple myeloma (MM) (1) Non small cell lung cancer (NSCLC) (3) Non-Hodgkin B-cell lymphomas (1) Non-Hodgkin’s lymphoma (NHL) (1) Prostate cancer (1) Small cell lung cancer (SCLC) (1) Soft tissue infections (1) Solid tumours (7) Type 2 diabetes (1) Streptococcal infection (1) Testicular cancer (1) Colon cancer (1) Staphylococcus aureus bloodstream infections (1) Metastatic non-small cell lung cancer (1) Biliary cancer (1) Kaposi's sarcoma (1) Renal carcinoma (1) Hematological cancer (1) Gram-positive bacterial infection (1) Gram-negative bacterial infection (1) Acute radiation syndrome (1) Ewing's Sarcoma (1) Stem cell mobilization (1) Brain cancer (1) Liver cancer (2) Thelassemia (1) Pseudomonas aeruginosa infection (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top